NDC 81033-102 – Guaifenesin
Guaifenesin 100 mg/5mL · Liquid · Oral
Product NDC81033-102
Product details
- Brand name
- Guaifenesin
- Generic name
- Guaifenesin
- Labeler
- KESIN PHARMA CORPORATION
- Dosage form
- Liquid
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M012
- Marketed since
- November 20, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant
Active ingredients
- Guaifenesin 100 mg/5mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 81033-102-16 | 473 mL in 1 BOTTLE (81033-102-16) | Apr 1, 2025 |
| 81033-102-51 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-102-51) / 5 mL in 1 CUP, UNIT-DOSE (81033-102-05) | Nov 20, 2023 |
| 81033-102-52 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-102-52) / 10 mL in 1 CUP, UNIT-DOSE (81033-102-10) | Nov 20, 2023 |
Other Guaifenesin products
- 80513-413 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Advanced Rx LLC
- 60687-874 Guaifenesin 300 mg/15mL · Solution · American Health Packaging
- 60687-863 Guaifenesin 200 mg/10mL · Solution · American Health Packaging
- 60687-852 Guaifenesin 100 mg/5mL · Solution · American Health Packaging
- 46122-750 Guaifenesin 600 mg/1 · Tablet, Extended Release · AMERISOURCE BERGEN
- 65162-036 Guaifenesin 600 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 65162-037 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 24689-144 Guaifenesin 400 mg/1 · Tablet · APNAR PHARMA LP
- 58602-810 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-853 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-865 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-864 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC